200Curated trials
Enterprise Evidence Report · NR-REPORT-V2.0
Netherlands
Neuroscience Intelligence
Netherlands neuroscience evidence report: current clinical, research, institution and source-linked intelligence.
Evidence rank #10 of 50 · Data maturity A · Research score 45.2 · Data confidence 100.0 / 100 · Snapshot 2026-10-12 03:34 UTC.
60Recruiting trials
486Publications
168Institutions
Executive interpretation
Netherlands ranks #10 in the current NeuroRisk evidence-ranked market layer. This ranking summarizes indexed clinical, publication and institution evidence; it is not a probability of commercial success and not an investment recommendation.
Methodology status
Methodology NR-REPORT-V2.0. No synthetic ML confidence is presented as scientific probability. Counts and source links below are tied to the generation snapshot.
Methodology →Leading sponsors
Radboud University Medical Center162 recruiting
Maastricht University Medical Center102 recruiting
Hoffmann-La Roche92 recruiting
Merck Sharp & Dohme LLC84 recruiting
University Medical Center Groningen83 recruiting
UMC Utrecht73 recruiting
Erasmus Medical Center61 recruiting
Amsterdam UMC, location VUmc50 recruiting
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)41 recruiting
Bayer42 recruiting
Disease activity
Parkinsons33trials
Alzheimers28trials
Epilepsy19trials
Other Neurology14trials
Stroke9trials
Neuromuscular7trials
Adhd7trials
Pain Neuropathy7trials
Other Psychiatry6trials
Autism6trials
Research institutions
Netherlands Haemophilia SocietyOpenAlexlinked institution
Ziekenhuis BernhovenOpenAlexlinked institution
Netherlands Heart InstituteOpenAlexlinked institution
Sint MaartenskliniekOpenAlexlinked institution
De ViersprongOpenAlexlinked institution
Amsterdam Institute for Addiction ResearchOpenAlexlinked institution
LentisOpenAlexlinked institution
Medisch Centrum AlkmaarOpenAlexlinked institution
Amphia ZiekenhuisOpenAlexlinked institution
Maasstad ZiekenhuisOpenAlexlinked institution
Clinical evidence trail
NCT07798674TreatHSP Platform: Adaptive Natural History Platform for Ataxias, HSPs, and Spastic AtaxiasRECRUITING
NCT07786883Dialectic Behaviour Therapy (DBT) for People With Autism: A Multiple Baseline Single Case DesignRECRUITING
NCT07668856Cannabidiol as add-on Therapy for Children With Refractory Epilepsy (CBD-uN1que), a High-quality Individualized Approach: a Series of N-of-1 TrialsRECRUITING
NCT07586150Personalized Pharmaco-Lifestyle Interventions for Severe Mental Illnesses (LIFETRAIN)NOT_YET_RECRUITING
NCT07322887A Phase 2 Study to Assess the Effects of SUL-238 on High Energy Phosphates With ³¹P-MRS in Patients With Early, Untreated Parkinson's DiseaseRECRUITING
NCT07259005Breathe Hard to Breathe Easy: Online Breathwork-Assisted Therapy for Social AnxietyRECRUITING
NCT07252739KEYMAKER-U01 Substudy 01J: A Study of Pembrolizumab Plus MK-1084 in Participants With Non-Small Cell Lung Cancer (NSCLC) With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) G12C Mutations (MK-3475-01J/KEYMAKER-U01J)RECRUITING
NCT07170150A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's DiseaseRECRUITING
NCT07111975ANEURYSM@RISK: Automatic Intracranial Aneurysm Quantification and Feature Learning Modelling to Optimize Intracranial Aneurysm Rupture PredictionACTIVE_NOT_RECRUITING
NCT07105280Closed-Loop Therapeutic Refinement Using Local Field Potentials in Parkinson's DiseaseNOT_YET_RECRUITING
Research evidence trail
PUBMEDThe relationship between product-based creativity and ADHD traits in children and the associations with later well-being.2027-02-01
PUBMEDPost-operative stun effect captured by local field potentials correlates to temporary symptom relief in an adolescent with dystonia: A case report.2026-12-01
PUBMEDModifiers of effectiveness and deterioration, and prognostic factors of adherence in internet-based interventions for treatment of perinatal depression: A systematic review and individual participant data meta-analysis.2026-12-01
PUBMEDHelping or controlling? A multi-method case study of a mother-daughter dyad and their interactions during trauma-focused therapy.2026-12-01
PUBMEDRisk factors for revictimization during treatment in patients with co-occurring SUD and PTSD.2026-12-01
PUBMEDResilience in traumatised youth: qualitative study on therapists' perspectives and practices.2026-12-01
PUBMEDEvaluation of the effectiveness of EMDR therapy for children and adolescents in Ukraine during war.2026-12-01
PUBMEDExploring a novel perspective on dissociative symptoms in PTSD: A habit-goal framework.2026-12-01
PUBMEDOnline-delivered eye movement desensitization and reprocessing treatment for adults with post-traumatic stress disorder due to multiple traumas: a non-concurrent multiple baseline design.2026-12-01
World Bank context
Macro indicators are shown only where a timestamped World Bank source row exists. They are context, not NeuroRisk predictions.
Sources and provenance
ClinicalTrials.gov provides NCT evidence. PubMed/NCBI and OpenAlex provide research metadata. OpenAlex links institutions. World Bank indicators are included only when an explicit source row and year exist. NeuroRisk transformations add normalization, ranking and graph connections.
Limitations
Indexed corpus counts are not guaranteed exhaustive global totals. Scores are comparative decision-support signals. This report is not medical advice, regulatory advice, patent clearance, an investment recommendation or a guarantee of outcome.